Sol-gel technologies to participate in the h.c. wainwright 25th annual global investment conference

Ness ziona, israel, aug. 30, 2023 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin conditions, and with two approved large-category dermatology products, epsolay and twyneo, today announced that the company will virtually present at the h.c. wainwright 25th annual global investment conference, being held september 11-13, 2023.
SLGL Ratings Summary
SLGL Quant Ranking